• Investing in Pharma (Part 1) - Divi's Laboratories

  • Jan 8 2024
  • Length: 11 mins
  • Podcast

Investing in Pharma (Part 1) - Divi's Laboratories

Listen for free

View show details

  • Summary

  • Investing in Pharma (Part 1) - Divi's Laboratories

    Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.

    Read the full blog here
    Show More Show Less
Show More Show Less

What listeners say about Investing in Pharma (Part 1) - Divi's Laboratories

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.